Working… Menu

Cabozantinib S-malate and Nivolumab With or Without Ipilimumab in Treating Patients With Metastatic Genitourinary Tumors

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02496208
Recruitment Status : Active, not recruiting
First Posted : July 14, 2015
Last Update Posted : October 4, 2021
Information provided by (Responsible Party):
National Cancer Institute (NCI)